{"doc_id": "si-2022-0270-reg-1", "parent_doc_id": "si-2022-0270", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "1. (1) These Regulations may be cited as the Medicinal Products (Safety", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products (Safety \n\nFeatures on Packaging) Regulations 2022. \n\n(2) The Regulations of 2019 and these Regulations may be cited together \nas the Medicinal Products (Safety Features on Packaging) Regulations 2019 \nand 2022. \n\nInterpretation", "text_norm": "1 (1) regulation may cited medicinal product (safety feature packaging) regulation 2022 (2) regulation 2019 regulation may cited together medicinal product (safety feature packaging) regulation 2019 2022 interpretation", "start_char": 879, "end_char": 1173, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-2", "parent_doc_id": "si-2022-0270", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "2. (1) In these Regulations—", "text_raw": "2. (1) In these Regulations— \n\n“Authority” means the Health Products Regulatory Authority; \n\n“Directive” means Directive 2001/83/EC of the European Parliament and of \nthe Council of 6 November 20014, as amended from time to time; \n\n“EU Regulation” means Commission Delegated Regulation (EU) 2016/161 of \n2 October 20151, as amended by Commission Delegated Regulation (EU) \n2021/1686 of 7 July 20212 and Commission Delegated Regulation (EU) \n2022/315 of 17 December 20213; \n\n“health centre” means a health centre under the management or control of a \nhospital; \n\n“healthcare institution” means a hospital, in- or outpatient clinic or health \ncentre; \n\n “hub” means the central information and data router of the repositories system \nreferred to in Article 32 of the EU Regulation; \n\n1 OJ No. L 32, 9.2.2016, p. 1. \n2 OJ No. L 332, 21.9.2021, p. 1. \n3 OJ No. L 55, 28.2.2022, p. 33. \n4 OJ No. L 311, 28.11.2001, p. 67. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 3rd June, 2022. \n\n \n \n \n \n \n \n\f[270] 3 \n\n“in- or outpatient clinic” means an in- or outpatient, or day patient, clinic under \nthe management or control of a hospital; \n\n“manufacturer” means the holder of a manufacturer’s authorisation, as defined \nin Regulation 3(1) of the Medicinal Products (Control of Manufacture) \nRegulations 2007 (S.I. No. 539 of 2007); \n\n“marketing authorisation holder” means \nthe holder of a marketing \nauthorisation, as defined in Regulation 3(1) of the Medicinal Products (Control \nof Placing on the Market) Regulations 2007 (S.I. No. 540 of 2007); \n\n“packaging” means outer packaging or, in the case of a medicinal product with \nno outer packaging, the immediate packaging; \n\n“Regulations of 2019” means the Medicinal Products (Safety Features on \nPackaging) Regulations 2019 (S.I. No. 36 of 2019); \n\n“repositories system” means the system to be set up and managed under \nChapter VII of the EU Regulation; \n\n“safety features” means the unique identifier and anti-tampering device \nrequired to be placed on the packaging of medicinal products under the EU \nRegulation; \n\n“Society” means the Pharmaceutical Society of Ireland; \n\n“wholesaler” means the holder of a wholesaler’s authorisation, as defined in \nRegulation 4(1) of the Medicinal Products (Control of Wholesale Distribution) \nRegulations 2007 (S.I. No. 538 of 2007) and, for the avoidance of doubt, does \nnot include a pharmacist supplying medicinal products pursuant to Regulation \n6(c) of those Regulations. \n\n(2) A word or expression that is used in these Regulations and is also used \nin the EU Regulation or the Directive has, unless the context otherwise \nrequires, the same meaning in these Regulations that it has in the EU \nRegulation or the Directive. \n\nScope", "text_norm": "2 (1) regulations-- authority mean health product regulatory authority directive mean directive 2001 83 ec european parliament council 6 november 20014 amended time time eu regulation mean commission delegated regulation (eu) 2016 161 2 october 20151 amended commission delegated regulation (eu) 2021 1686 7 july 20212 commission delegated regulation (eu) 2022 315 17 december 20213 health centre mean health centre management control hospital healthcare institution mean hospital in- outpatient clinic health centre hub mean central information data router repository system referred article 32 eu regulation 1 oj no l 32 9.2.2016 p 1 2 oj no l 332 21.9.2021 p 1 3 oj no l 55 28.2.2022 p 33 4 oj no l 311 28.11.2001 p 67 notice making statutory instrument published iris oifigiuil 3rd june 2022 270 3 in- outpatient clinic mean in- outpatient day patient clinic management control hospital manufacturer mean holder manufacturer authorisation defined regulation 3(1) medicinal product (control manufacture) regulation 2007 (s.i no 539 2007) marketing authorisation holder mean holder marketing authorisation defined regulation 3(1) medicinal product (control placing market) regulation 2007 (s.i no 540 2007) packaging mean outer packaging case medicinal product outer packaging immediate packaging regulation 2019 mean medicinal product (safety feature packaging) regulation 2019 (s.i no 36 2019) repository system mean system set managed chapter vii eu regulation safety feature mean unique identifier anti-tampering device required placed packaging medicinal product eu regulation society mean pharmaceutical society ireland wholesaler mean holder wholesaler authorisation defined regulation 4(1) medicinal product (control wholesale distribution) regulation 2007 (s.i no 538 2007) avoidance doubt include pharmacist supplying medicinal product pursuant regulation 6(c) regulation (2) word expression used regulation also used eu regulation directive unless context otherwise requires meaning regulation eu regulation directive scope", "start_char": 1173, "end_char": 3939, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-3", "parent_doc_id": "si-2022-0270", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "3. These Regulations apply to—", "text_raw": "3. These Regulations apply to— \n\n(a) medicinal products subject to prescription other than those listed \n\nin Annex I to the EU Regulation, and \n\n(b) medicinal products which are not subject to prescription and are \n\nlisted in Annex II to the EU Regulation. \n\nPART 2 \n\nOFFENCES – GENERAL \n\nPlacing of unique identifier on packaging", "text_norm": "3 regulation apply to-- (a) medicinal product subject prescription listed annex eu regulation (b) medicinal product subject prescription listed annex ii eu regulation part 2 offence - general placing unique identifier packaging", "start_char": 3939, "end_char": 4272, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-4", "parent_doc_id": "si-2022-0270", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "4. A person who places on the market a medicinal product which does not", "text_raw": "4. A person who places on the market a medicinal product which does not \n\nhave a unique identifier placed on its packaging is guilty of an offence. \n\n \n \n \n \n\f4 [270] \n\nComposition of unique identifier", "text_norm": "4 person place market medicinal product unique identifier placed packaging guilty offence 4 270 composition unique identifier", "start_char": 4272, "end_char": 4476, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-5", "parent_doc_id": "si-2022-0270", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "5. A person who places on the market a medicinal product with a unique", "text_raw": "5. A person who places on the market a medicinal product with a unique \nidentifier which fails to comply with the technical specifications set out in \nArticle 4 of the EU Regulation is guilty of an offence. \n\nCarrier of unique identifier", "text_norm": "5 person place market medicinal product unique identifier fails comply technical specification set article 4 eu regulation guilty offence carrier unique identifier", "start_char": 4476, "end_char": 4716, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-6", "parent_doc_id": "si-2022-0270", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "6. A person who places on the market a medicinal product with a unique", "text_raw": "6. A person who places on the market a medicinal product with a unique \nidentifier encoded otherwise than in accordance with Article 5 of the EU \nRegulation is guilty of an offence. \n\nQuality of printing of unique identifier", "text_norm": "6 person place market medicinal product unique identifier encoded otherwise accordance article 5 eu regulation guilty offence quality printing unique identifier", "start_char": 4716, "end_char": 4943, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-7", "parent_doc_id": "si-2022-0270", "section_id": "reg-7", "section_label": "Regulation 7.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "7. A person who places on the market a medicinal product with a unique", "text_raw": "7. A person who places on the market a medicinal product with a unique \nidentifier which does not comply with the quality of printing requirements set \nout in Article 6 of the EU Regulation is guilty of an offence. \n\nHuman-readable elements of unique identifier", "text_norm": "7 person place market medicinal product unique identifier comply quality printing requirement set article 6 eu regulation guilty offence human-readable element unique identifier", "start_char": 4943, "end_char": 5207, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-8", "parent_doc_id": "si-2022-0270", "section_id": "reg-8", "section_label": "Regulation 8.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "8. (1) Subject to paragraph (2), a person who places on the market a", "text_raw": "8. (1) Subject to paragraph (2), a person who places on the market a \nmedicinal product which does not have the data elements listed in Article 7(1) \nof the EU Regulation (other than subparagraph (c) thereof) on its packaging in \nhuman-readable format is guilty of an offence. \n\n(2) Paragraph (1) shall not apply where the sum of the two longest \n\ndimensions of the packaging equals or is less than 10 centimetres. \n\n(3) Subject to paragraph (4), a person who places on the market a medicinal \nproduct which does not have the human-readable data elements referred to in \nparagraph (1) adjacent to the two-dimensional barcode carrying the unique \nidentifier is guilty of an offence. \n\n(4) Paragraph (3) shall not apply where the dimensions of the packaging of \nthe medicinal product do not allow for the human-readable data elements to be \nadjacent to the two dimensional barcode. \n\nOther barcodes on packaging", "text_norm": "8 (1) subject paragraph (2) person place market medicinal product data element listed article 7(1) eu regulation (other subparagraph (c) thereof) packaging human-readable format guilty offence (2) paragraph (1) shall apply sum two longest dimension packaging equal le 10 centimetre (3) subject paragraph (4) person place market medicinal product human-readable data element referred paragraph (1) adjacent two-dimensional barcode carrying unique identifier guilty offence (4) paragraph (3) shall apply dimension packaging medicinal product allow human-readable data element adjacent two dimensional barcode barcodes packaging", "start_char": 5207, "end_char": 6119, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-9", "parent_doc_id": "si-2022-0270", "section_id": "reg-9", "section_label": "Regulation 9.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "9. A person who places on the market a medicinal product which has on its", "text_raw": "9. A person who places on the market a medicinal product which has on its \npackaging, for the purpose of identification and verification of authenticity, any \nvisible two-dimensional barcode other than the two-dimensional barcode \ncarrying the unique identifier, is guilty of an offence. \n\nUnique identifiers which have been decommissioned", "text_norm": "9 person place market medicinal product packaging purpose identification verification authenticity visible two-dimensional barcode two-dimensional barcode carrying unique identifier guilty offence unique identifier decommissioned", "start_char": 6119, "end_char": 6461, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-10", "parent_doc_id": "si-2022-0270", "section_id": "reg-10", "section_label": "Regulation 10.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "10. (1) Subject to paragraph (2), a person who further distributes or supplies", "text_raw": "10. (1) Subject to paragraph (2), a person who further distributes or supplies \nto the public a medicinal product bearing a unique identifier which has been \ndecommissioned is guilty of an offence. \n\n \n \n \n \n \n \n\f[270] 5 \n\n(2) Paragraph (1) shall not apply where one of the exceptions listed in \n\nArticle 12 of the EU Regulation applies. \n\nReversing the status of decommissioned unique identifier", "text_norm": "10 (1) subject paragraph (2) person distributes supply public medicinal product bearing unique identifier decommissioned guilty offence 270 5 (2) paragraph (1) shall apply one exception listed article 12 eu regulation applies reversing status decommissioned unique identifier", "start_char": 6461, "end_char": 6860, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-11", "parent_doc_id": "si-2022-0270", "section_id": "reg-11", "section_label": "Regulation 11.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "11. (1) Subject to paragraph (2), a person who reverses the status of a", "text_raw": "11. (1) Subject to paragraph (2), a person who reverses the status of a \n\ndecommissioned unique identifier is guilty of an offence. \n\n(2) Paragraph (1) shall not apply where the conditions listed in Article 13(1) \n\nof the EU Regulation are fulfilled. \n\nRecord keeping", "text_norm": "11 (1) subject paragraph (2) person revers status decommissioned unique identifier guilty offence (2) paragraph (1) shall apply condition listed article 13(1) eu regulation fulfilled record keeping", "start_char": 6860, "end_char": 7130, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-12", "parent_doc_id": "si-2022-0270", "section_id": "reg-12", "section_label": "Regulation 12.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "12. A person who places on the market a medicinal product and fails to", "text_raw": "12. A person who places on the market a medicinal product and fails to \ncomply with the record keeping requirements set out in Article 15 of the EU \nRegulation in respect of such medicinal product is guilty of an offence. \n\nPART 3 \n\nOFFENCES BY MANUFACTURERS \n\nVerifications before removing or replacing safety features", "text_norm": "12 person place market medicinal product fails comply record keeping requirement set article 15 eu regulation respect medicinal product guilty offence part 3 offence manufacturer verification removing replacing safety feature", "start_char": 7130, "end_char": 7452, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-13", "parent_doc_id": "si-2022-0270", "section_id": "reg-13", "section_label": "Regulation 13.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "13. A manufacturer who fails to perform verifications required under Articles", "text_raw": "13. A manufacturer who fails to perform verifications required under Articles \n16 and 17 of the EU Regulation before removing, covering (either fully or \npartially) or replacing safety features is guilty of an offence. \n\nActions to be taken by manufacturers in case of tampering or suspected \nfalsification", "text_norm": "13 manufacturer fails perform verification required article 16 17 eu regulation removing covering (either fully partially) replacing safety feature guilty offence action taken manufacturer case tampering suspected falsification", "start_char": 7452, "end_char": 7761, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-14", "parent_doc_id": "si-2022-0270", "section_id": "reg-14", "section_label": "Regulation 14.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "14. (1) Where a manufacturer has reason to believe that—", "text_raw": "14. (1) Where a manufacturer has reason to believe that— \n\n(a) \n\n(b) \n\nthe packaging of a medicinal product has been tampered with, or \n\nthe verification of the safety features on a medicinal product \nindicates that the product may not be authentic, \n\nthe manufacturer is guilty of an offence if he or she— \n\n(i) \n\n(ii) \n\nplaces the medicinal product on the market, or \n\nfails to immediately inform the Authority after forming such \nbelief. \n\nPART 4 \n\nOFFENCES BY WHOLESALERS \n\nVerification of authenticity of unique identifier", "text_norm": "14 (1) manufacturer reason believe that-- (a) (b) packaging medicinal product tampered verification safety feature medicinal product indicates product may authentic manufacturer guilty offence she-- (i) (ii) place medicinal product market fails immediately inform authority forming belief part 4 offence wholesaler verification authenticity unique identifier", "start_char": 7761, "end_char": 8291, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-15", "parent_doc_id": "si-2022-0270", "section_id": "reg-15", "section_label": "Regulation 15.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "15. (1) Subject to paragraph (2), a wholesaler in physical possession of a", "text_raw": "15. (1) Subject to paragraph (2), a wholesaler in physical possession of a \nmedicinal product referred to in Article 20(a) or (b) of the EU Regulation who \nfails to verify the authenticity of the unique identifier on the product is guilty of \nan offence. \n\n \n \n \n \n \n \n\f6 [270] \n\n(2) Paragraph (1) shall not apply in the case of a medicinal product referred \nto in Article 20(b) of the EU Regulation in any of the situations listed in Article \n21 of the EU Regulation. \n\nDecommissioning of unique identifiers", "text_norm": "15 (1) subject paragraph (2) wholesaler physical possession medicinal product referred article 20(a) (b) eu regulation fails verify authenticity unique identifier product guilty offence 6 270 (2) paragraph (1) shall apply case medicinal product referred article 20(b) eu regulation situation listed article 21 eu regulation decommissioning unique identifier", "start_char": 8291, "end_char": 8802, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-16", "parent_doc_id": "si-2022-0270", "section_id": "reg-16", "section_label": "Regulation 16.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "16. A wholesaler in physical possession of a medicinal product referred to in", "text_raw": "16. A wholesaler in physical possession of a medicinal product referred to in \nArticle 22 of the EU Regulation who fails to verify the authenticity of, and \ndecommission, the unique identifier of the product is guilty of an offence. \n\nVerifications of medicinal products for United Kingdom market", "text_norm": "16 wholesaler physical possession medicinal product referred article 22 eu regulation fails verify authenticity decommission unique identifier product guilty offence verification medicinal product united kingdom market", "start_char": 8802, "end_char": 9101, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-17", "parent_doc_id": "si-2022-0270", "section_id": "reg-17", "section_label": "Regulation 17.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "17. In the case of a shipment of medicinal products manufactured and", "text_raw": "17. In the case of a shipment of medicinal products manufactured and \nlabelled for the United Kingdom market, a wholesaler who fails to perform \nadequate verifications to ensure that the shipment complies with the \nrequirement to bear safety features under Article 54a(1) of Directive \n2001/83/EC when received from— \n\n(a) \n\n(b) \n\n(c) \n\nthe manufacturer, \n\nthe marketing authorisation holder, or \n\na wholesaler who is designated by the marketing authorisation \nholder, by means of a written contract, to store and distribute the \nproducts covered by his marketing authorisation on his behalf, \n\nis guilty of an offence. \n\nActions to be taken in case of tampering or suspected falsification", "text_norm": "17 case shipment medicinal product manufactured labelled united kingdom market wholesaler fails perform adequate verification ensure shipment complies requirement bear safety feature article 54a(1) directive 2001 83 ec received from-- (a) (b) (c) manufacturer marketing authorisation holder wholesaler designated marketing authorisation holder mean written contract store distribute product covered marketing authorisation behalf guilty offence action taken case tampering suspected falsification", "start_char": 9101, "end_char": 9793, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-18", "parent_doc_id": "si-2022-0270", "section_id": "reg-18", "section_label": "Regulation 18.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "18. (1) Where a wholesaler has reason to believe that—", "text_raw": "18. (1) Where a wholesaler has reason to believe that— \n\n(a) \n\n(b) \n\nthe packaging of a medicinal product has been tampered with, or \n\nthe verification of the safety features on a medicinal product \nindicates that the product may not be authentic, \n\nthe wholesaler is guilty of an offence if he or she— \n\n(i) \n\ndistributes the medicinal product, or \n\n(ii) \n\nfails to immediately inform the Authority after forming such \nbelief. \n\nVerification and decommissioning before supply", "text_norm": "18 (1) wholesaler reason believe that-- (a) (b) packaging medicinal product tampered verification safety feature medicinal product indicates product may authentic wholesaler guilty offence she-- (i) distributes medicinal product (ii) fails immediately inform authority forming belief verification decommissioning supply", "start_char": 9793, "end_char": 10272, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-19", "parent_doc_id": "si-2022-0270", "section_id": "reg-19", "section_label": "Regulation 19.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "19. A wholesaler who fails to comply with Regulation 5(2) of the", "text_raw": "19. A wholesaler who fails to comply with Regulation 5(2) of the \n\nRegulations of 2019, where applicable, is guilty of an offence. \n\n \n \n \n \n \n \n \n\f[270] 7 \n\nPART 5 \n\nOFFENCES BY PERSONS AUTHORISED TO SUPPLY MEDICINAL \nPRODUCTS TO THE PUBLIC \n\nVerification and decommissioning", "text_norm": "19 wholesaler fails comply regulation 5(2) regulation 2019 applicable guilty offence 270 7 part 5 offence person authorised supply medicinal product public verification decommissioning", "start_char": 10272, "end_char": 10551, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-20", "parent_doc_id": "si-2022-0270", "section_id": "reg-20", "section_label": "Regulation 20.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "20. (1) Subject to paragraph (2), a person authorised to supply medicinal", "text_raw": "20. (1) Subject to paragraph (2), a person authorised to supply medicinal \nproducts to the public who fails to verify the safety features and decommission \nthe unique identifier of any medicinal product bearing safety features, in \naccordance with Article 25(3) of the EU Regulation— \n\n(a) before supplying that product to the public, \n\n(b) \n\n(c) \n\n(d) \n\n(e) \n\nin the case of a person operating within a healthcare institution, \nbetween the delivery of the product to the healthcare institution \nand the sale or supplying of it to the public, \n\nin the case of a medicinal product that cannot be returned to the \nwholesaler or manufacturer, while the product is in his or her \nphysical possession, \n\nin the case of a medicinal product that is requested as a sample \nby the Authority or the Society, prior to providing such sample, \n\nin the case of a medicinal product that he or she supplies for \nsubsequent use as authorised investigational medicinal products \nor authorised auxiliary medicinal products as defined in Article \n2(2)(9) and (10) of Regulation (EU) No. 536/2014 of the \nEuropean Parliament and of the Council of 16 April 20145, at \nthe time of such supply, \n\n(f) \n\nin the case of the supply of only part of a pack of a medicinal \nproduct the unique identifier of which is not decommissioned, \nwhen the pack is opened for the first time, or \n\n(g) where there are technical problems preventing verification and \n\ndecommissioning, as soon as those problems are solved, \n\nis guilty of an offence. \n\n(2) Paragraph (1) shall not apply— \n\n(a) \n\nin the case of a medicinal product provided, to a person \nauthorised or entitled to supply medicinal products to the public, \nas a free sample in accordance with Article 96 of the Directive, \nand \n\n(b) where the obligation to verify and decommission is on the \n\nwholesaler pursuant to Article 5(2) of the Regulations of 2019. \n\n(3) Where paragraph (2)(b) applies, a person authorised to supply medicinal \nproducts to the public who fails to verify the authenticity of the anti-tampering \ndevice at the time the medicinal product is supplied to the public is guilty of an \noffence. \n\n5 OJ No. L 158, 27.5.2014, p. 1. \n\n \n \n \n \n\f8 [270] \n\nActions to be taken in case of tampering or suspected falsification", "text_norm": "20 (1) subject paragraph (2) person authorised supply medicinal product public fails verify safety feature decommission unique identifier medicinal product bearing safety feature accordance article 25(3) eu regulation-- (a) supplying product public (b) (c) (d) (e) case person operating within healthcare institution delivery product healthcare institution sale supplying public case medicinal product cannot returned wholesaler manufacturer product physical possession case medicinal product requested sample authority society prior providing sample case medicinal product supply subsequent use authorised investigational medicinal product authorised auxiliary medicinal product defined article 2(2)(9) (10) regulation (eu) no 536 2014 european parliament council 16 april 20145 time supply (f) case supply part pack medicinal product unique identifier decommissioned pack opened first time (g) technical problem preventing verification decommissioning soon problem solved guilty offence (2) paragraph (1) shall apply-- (a) case medicinal product provided person authorised entitled supply medicinal product public free sample accordance article 96 directive (b) obligation verify decommission wholesaler pursuant article 5(2) regulation 2019 (3) paragraph (2)(b) applies person authorised supply medicinal product public fails verify authenticity anti-tampering device time medicinal product supplied public guilty offence 5 oj no l 158 27.5.2014 p 1 8 270 action taken case tampering suspected falsification", "start_char": 10551, "end_char": 12810, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-21", "parent_doc_id": "si-2022-0270", "section_id": "reg-21", "section_label": "Regulation 21.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "21. (1) Where a person authorised to supply medicinal products to the public", "text_raw": "21. (1) Where a person authorised to supply medicinal products to the public \n\nhas reason to believe that— \n\n(a) \n\n(b) \n\nthe packaging of a medicinal product has been tampered with, or \n\nthe verification of the safety features on a medicinal product \nindicates that the product may not be authentic, \n\nthe person is guilty of an offence if he or she— \n\n(i) \n\nsupplies the medicinal product, or \n\n(ii) \n\nfails to immediately inform the Authority after forming such \nbelief. \n\nPART 6 \n\nOFFENCES BY MARKETING AUTHORISATION HOLDERS, PARALLEL \nIMPORTERS AND PARALLEL DISTRIBUTORS \n\nUploading of information in repositories system", "text_norm": "21 (1) person authorised supply medicinal product public reason believe that-- (a) (b) packaging medicinal product tampered verification safety feature medicinal product indicates product may authentic person guilty offence she-- (i) supply medicinal product (ii) fails immediately inform authority forming belief part 6 offence marketing authorisation holder parallel importer parallel distributor uploading information repository system", "start_char": 12810, "end_char": 13437, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-22", "parent_doc_id": "si-2022-0270", "section_id": "reg-22", "section_label": "Regulation 22.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "22. (1) Subject to paragraph (2), a marketing authorisation holder who fails", "text_raw": "22. (1) Subject to paragraph (2), a marketing authorisation holder who fails \n\nto— \n\n(a) upload the information referred to in Article 33(2) of the EU \nRegulation to the repositories system, in the manner required \nunder Article 33(3) of the EU Regulation, before releasing the \nmedicinal product for sale or distribution by the manufacturer, \nor \n\n(b) keep such information up to date thereafter, \n\nis guilty of an offence. \n\n(2) Paragraph (1) shall not apply in the case of parallel imported or parallel \ndistributed medicinal products bearing an equivalent unique identifier for the \npurposes of complying with Article 47a of the Directive. \n\n(3) In the case of parallel imported or parallel distributed medicinal products \nbearing an equivalent unique identifier for the purposes of complying with \nArticle 47a of the Directive, if the person responsible for placing the products \non the market fails to— \n\n(a) upload the information referred to in Article 33(2) of the EU \nRegulation to the repositories system, in the manner required \nunder Article 33(3) of the EU Regulation, before releasing the \nmedicinal product for sale or distribution by the manufacturer, \nor \n\n(b) keep such information up to date thereafter, \n\nthat person is guilty of an offence. \n\n \n \n \n \n\f[270] 9 \n\nRepackaged or relabelled packs", "text_norm": "22 (1) subject paragraph (2) marketing authorisation holder fails to-- (a) upload information referred article 33(2) eu regulation repository system manner required article 33(3) eu regulation releasing medicinal product sale distribution manufacturer (b) keep information date thereafter guilty offence (2) paragraph (1) shall apply case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive (3) case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive person responsible placing product market fails to-- (a) upload information referred article 33(2) eu regulation repository system manner required article 33(3) eu regulation releasing medicinal product sale distribution manufacturer (b) keep information date thereafter person guilty offence 270 9 repackaged relabelled pack", "start_char": 13437, "end_char": 14754, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-23", "parent_doc_id": "si-2022-0270", "section_id": "reg-23", "section_label": "Regulation 23.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "23. For each batch of repackaged or relabelled packs of a medicinal product", "text_raw": "23. For each batch of repackaged or relabelled packs of a medicinal product \non which equivalent unique identifiers were placed for the purposes of \ncomplying with Article 47a of the Directive, the person responsible for placing \nthe medicinal product on the market is guilty of an offence if he or she fails to \nupload to the hub— \n\n(a) \n\n(b) \n\nthe batch number or numbers of the packs which are to be \nrepackaged or relabelled and of the unique identifiers on those \npacks, or \n\nthe batch number of the batch resulting from the repackaging or \nrelabelling operations and the equivalent unique identifiers in \nthat batch. \n\nProducts recalled, withdrawn or stolen", "text_norm": "23 batch repackaged relabelled pack medicinal product equivalent unique identifier placed purpose complying article 47a directive person responsible placing medicinal product market guilty offence fails upload hub-- (a) (b) batch number number pack repackaged relabelled unique identifier pack batch number batch resulting repackaging relabelling operation equivalent unique identifier batch product recalled withdrawn stolen", "start_char": 14754, "end_char": 15420, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-24", "parent_doc_id": "si-2022-0270", "section_id": "reg-24", "section_label": "Regulation 24.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "24. (1) Subject to paragraph (2), where a medicinal product is recalled,", "text_raw": "24. (1) Subject to paragraph (2), where a medicinal product is recalled, \nwithdrawn or stolen, and the marketing authorisation holder fails to take the \nmeasures set out in Article 40 of the EU Regulation, the marketing \nauthorisation holder is guilty of an offence. \n\n(2) Paragraph (1) shall not apply in the case of parallel imported or parallel \ndistributed medicinal products bearing an equivalent unique identifier for the \npurposes of complying with Article 47a of the Directive. \n\n(3) In the case of parallel imported or parallel distributed medicinal products \nbearing an equivalent unique identifier for the purposes of complying with \nArticle 47a of the Directive, where a medicinal product is recalled, withdrawn \nor stolen, and the person responsible for placing the product on the market fails \nto take the measures set out in Article 40 of the EU Regulation, that person is \nguilty of an offence. \n\nProducts to be supplied as free samples", "text_norm": "24 (1) subject paragraph (2) medicinal product recalled withdrawn stolen marketing authorisation holder fails take measure set article 40 eu regulation marketing authorisation holder guilty offence (2) paragraph (1) shall apply case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive (3) case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive medicinal product recalled withdrawn stolen person responsible placing product market fails take measure set article 40 eu regulation person guilty offence product supplied free sample", "start_char": 15420, "end_char": 16375, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-25", "parent_doc_id": "si-2022-0270", "section_id": "reg-25", "section_label": "Regulation 25.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "25. A marketing authorisation holder intending to supply a medicinal", "text_raw": "25. A marketing authorisation holder intending to supply a medicinal \nproduct as a free sample in accordance with Article 96 of the Directive, where \nthat product bears the safety features, who fails to— \n\n(a) \n\n(b) \n\nindicate it as a free sample in the repositories system, and \n\nensure the decommissioning of its unique identifier before \nproviding it to the persons qualified to prescribe it, \n\nis guilty of an offence. \n\nRemoval of unique identifiers from repositories system", "text_norm": "25 marketing authorisation holder intending supply medicinal product free sample accordance article 96 directive product bear safety feature fails to-- (a) (b) indicate free sample repository system ensure decommissioning unique identifier providing person qualified prescribe guilty offence removal unique identifier repository system", "start_char": 16375, "end_char": 16857, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-26", "parent_doc_id": "si-2022-0270", "section_id": "reg-26", "section_label": "Regulation 26.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "26. (1) Subject to paragraph (2), a marketing authorisation holder who", "text_raw": "26. (1) Subject to paragraph (2), a marketing authorisation holder who \nuploads unique identifiers in the repositories system before having removed \nfrom therein older unique identifiers containing the same product code and \nserial number as the unique identifiers being uploaded is guilty of an offence. \n\n \n \n \n \n\f10 [270] \n\n(2) Paragraph (1) shall not apply in the case of parallel imported or parallel \ndistributed medicinal products bearing an equivalent unique identifier for the \npurposes of complying with Article 47a of the Directive. \n\n(3) In the case of parallel imported or parallel distributed medicinal products \nbearing an equivalent unique identifier for the purposes of complying with \nArticle 47a of the Directive, where the person responsible for placing those \nmedicinal products on the market uploads unique identifiers in the repositories \nsystem before having removed from therein older unique identifiers containing \nthe same product code and serial number as the unique identifiers being \nuploaded, that person is guilty of an offence. \n\nPART 7 \n\nOFFENCES BY ENTITIES MANAGING REPOSITORIES \n\nObligations of legal entities establishing and managing repository in State", "text_norm": "26 (1) subject paragraph (2) marketing authorisation holder uploads unique identifier repository system removed therein older unique identifier containing product code serial number unique identifier uploaded guilty offence 10 270 (2) paragraph (1) shall apply case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive (3) case parallel imported parallel distributed medicinal product bearing equivalent unique identifier purpose complying article 47a directive person responsible placing medicinal product market uploads unique identifier repository system removed therein older unique identifier containing product code serial number unique identifier uploaded person guilty offence part 7 offence entity managing repository obligation legal entity establishing managing repository state", "start_char": 16857, "end_char": 18052, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-27", "parent_doc_id": "si-2022-0270", "section_id": "reg-27", "section_label": "Regulation 27.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "27. A legal entity managing a repository in the State, as part of the", "text_raw": "27. A legal entity managing a repository in the State, as part of the \nrepositories system, which fails to perform any of the actions listed in Article \n37 of the EU Regulation is guilty of an offence. \n\nData protection and data ownership", "text_norm": "27 legal entity managing repository state part repository system fails perform action listed article 37 eu regulation guilty offence data protection data ownership", "start_char": 18052, "end_char": 18293, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-28", "parent_doc_id": "si-2022-0270", "section_id": "reg-28", "section_label": "Regulation 28.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "28. (1) Subject to paragraph (2), a legal entity managing a repository in the", "text_raw": "28. (1) Subject to paragraph (2), a legal entity managing a repository in the \nState, as part of the repositories system, which accesses an audit trail (as \nreferred to in Article 35(1)(g) of the EU Regulation) and the data contained \ntherein without the written agreement of the legitimate data owners, as \ndesignated by Article 38(1) of the EU Regulation, is guilty of an offence. \n\n(2) Paragraph (1) shall not apply in the case of access for the purpose of \ninvestigating potential incidents of falsification flagged in the system in \naccordance with Article 36(b) of the EU Regulation. \n\nAccess by Authority", "text_norm": "28 (1) subject paragraph (2) legal entity managing repository state part repository system access audit trail (as referred article 35(1)(g) eu regulation) data contained therein without written agreement legitimate data owner designated article 38(1) eu regulation guilty offence (2) paragraph (1) shall apply case access purpose investigating potential incident falsification flagged system accordance article 36(b) eu regulation access authority", "start_char": 18293, "end_char": 18907, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-29", "parent_doc_id": "si-2022-0270", "section_id": "reg-29", "section_label": "Regulation 29.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "29. A legal entity managing a repository used to verify the authenticity of or", "text_raw": "29. A legal entity managing a repository used to verify the authenticity of or \ndecommission the unique identifiers of medicinal products placed on the \nmarket in the State, as part of the repositories system, which refuses to grant \nthe Authority access to that repository and the information contained therein \nfor one of the purposes listed in Article 39 of the EU Regulation is guilty of an \noffence. \n\nPART 8 \n\nTRANSITIONAL PROVISIONS \n\nTransitional provisions", "text_norm": "29 legal entity managing repository used verify authenticity decommission unique identifier medicinal product placed market state part repository system refuse grant authority access repository information contained therein one purpose listed article 39 eu regulation guilty offence part 8 transitional provision transitional provision", "start_char": 18907, "end_char": 19375, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-reg-30", "parent_doc_id": "si-2022-0270", "section_id": "reg-30", "section_label": "Regulation 30.", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "30. (1) A person is not guilty of an offence under these Regulations where", "text_raw": "30. (1) A person is not guilty of an offence under these Regulations where \nhe or she distributes or supplies to the public a medicinal product that had been \nplaced on the market without the safety features in the State before the coming \n\n \n \n \n \n \n\f[270] 11\n\ninto operation of these Regulations, provided the medicinal product is not \nrepackaged or relabelled thereafter, until the expiry date of the medicinal \nproduct. \n\n(2) Notwithstanding Regulation 17, until 31 December 2024 a wholesaler is\nnot guilty of an offence for failure to verify the authenticity of and \ndecommission the unique identifier of a medicinal product referred to in \nArticle 22(a) of the EU Regulation where the medicinal product is \nmanufactured and labelled for the United Kingdom market or for the United \nKingdom market and the markets of Cyprus, Malta or the State, and which the \nwholesaler intends to distribute in the United Kingdom. \n\nGIVEN under my Official Seal, \n\n1 June, 2022. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n\f12 [270]", "text_norm": "30 (1) person guilty offence regulation distributes supply public medicinal product placed market without safety feature state coming 270 11 operation regulation provided medicinal product repackaged relabelled thereafter expiry date medicinal product (2) notwithstanding regulation 17 31 december 2024 wholesaler guilty offence failure verify authenticity decommission unique identifier medicinal product referred article 22(a) eu regulation medicinal product manufactured labelled united kingdom market united kingdom market market cyprus malta state wholesaler intends distribute united kingdom given official seal 1 june 2022 stephen donnelly minister health 12 270", "start_char": 19375, "end_char": 20400, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
{"doc_id": "si-2022-0270-explanatory-note", "parent_doc_id": "si-2022-0270", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 270 of 2022", "title": "Irish Medicines Board Act 1995 (No. 29 of 1995) and for the purpose of giving", "year": 2022, "heading": "(This note is not part of the Instrument and does not purport to be a", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a \nlegal interpretation.) \n\nThe purpose of these Regulations is to introduce offences for breaches \nof Commission Delegated Regulation (EU) 2016/16 of 2 October 2015 \nand related offences. \n\nThese Regulations may be cited as the Medicinal Products (Safety Features \non Packaging) Regulations 2022. \n\n\f[270] 13 \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€3.50 \n\n(DH-423) 75. 6/22. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) purpose regulation introduce offence breach commission delegated regulation (eu) 2016 16 2 october 2015 related offence regulation may cited medicinal product (safety feature packaging) regulation 2022 270 13 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur3.50 (dh-423) 75 6 22 propylon", "start_char": 20400, "end_char": 21281, "source_path": "downloads\\2022\\2022_0269.pdf", "extraction_method": "pdfminer", "checksum": "sha256:45df3eed86099f2f91989dbe2391662a6e8cb849f6719e60fe4495c3f72a7c17", "cross_refs": []}
